Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 927

1.

Epidemiological and immunological characteristics of HIV-infected patients on the cadaveric kidney donor waiting list at the Johannesburg renal transplant program.

Ngutshane BS, Sparaco A, Mayne ES.

AIDS Res Hum Retroviruses. 2019 Jan 8. doi: 10.1089/AID.2018.0193. [Epub ahead of print]

PMID:
30618265
2.

Promoting intestinal lymphatic transport targets a liver-X receptor (LXR) agonist (WAY-252,623) to lymphocytes and enhances immunomodulation.

Cao E, Lindgren A, Martinsson S, Hu L, Lindfors L, Sigfridsson K, Skantze U, Michaëlsson E, Trevaskis NL, Porter CJH.

J Control Release. 2019 Jan 3. pii: S0168-3659(19)30002-1. doi: 10.1016/j.jconrel.2019.01.002. [Epub ahead of print]

PMID:
30611901
3.

Optimal Timing of Hepatitis C Treatment among HIV/HCV Co-infected ESRD Patients: Pre vs. Post-Transplant.

Shelton BA, Berdahl G, Sawinski D, Linas BP, Reese PP, Mustian MN, Reed RD, MacLennan PA, Locke JE.

Am J Transplant. 2018 Dec 27. doi: 10.1111/ajt.15239. [Epub ahead of print]

PMID:
30589503
4.

Paracoccidioidomycosis in Immunocompromised Patients: A Literature Review.

de Almeida JN Jr, Peçanha PM, Colombo AL.

J Fungi (Basel). 2018 Dec 26;5(1). pii: E2. doi: 10.3390/jof5010002. Review.

5.

Disparity in access to kidney allograft offers among transplant candidates with human immunodeficiency virus.

Cohen JB, Locke JE, Shelton B, Reed RD, Mustian M, MacLennan P, Forde KA, Reese PP, Sawinski D.

Clin Transplant. 2018 Dec 21:e13466. doi: 10.1111/ctr.13466. [Epub ahead of print]

PMID:
30578590
6.

Clinical and Health Care Utilization Outcomes of Kidney Transplantation in HIV-Positive Recipients: A Nationwide Analysis From 2008-2013.

Apewokin S, Madan R, Restrepo A, Hemmige VS, Arora S.

Transplant Proc. 2018 Dec;50(10):3361-3366. doi: 10.1016/j.transproceed.2018.08.002. Epub 2018 Aug 10.

PMID:
30577208
7.

Successful treatment of genotype 3 hepatitis C infection in a noncirrhotic HIV infected patient on chronic dialysis with the combination of sofosbuvir and velpatasvir: A case report.

Begovac J, Krznarić J, Bogdanić N, Močibob L, Zekan Š.

Medicine (Baltimore). 2018 Dec;97(51):e13671. doi: 10.1097/MD.0000000000013671.

8.

Prevalence and outcomes of central venous catheter-related bacteraemia in HIV-infected versus non-HIV-infected patients undergoing haemodialysis treatment for end-stage kidney disease.

Avila-Danguillecourt N, Moodley AA, Makinga P.

South Afr J HIV Med. 2018 Nov 22;19(1):859. doi: 10.4102/sajhivmed.v19i1.859. eCollection 2018.

9.

New option for ART in patients with HIV on dialysis.

Ambrosioni J, Miro JM.

Lancet HIV. 2018 Dec 13. pii: S2352-3018(18)30290-X. doi: 10.1016/S2352-3018(18)30290-X. [Epub ahead of print] No abstract available.

PMID:
30555050
10.

Thrombotic thrombocytopenic purpura: A 5-year tertiary care centre experience.

Swart L, Schapkaitz E, Mahlangu JN.

J Clin Apher. 2019 Feb;34(1):44-50. doi: 10.1002/jca.21673. Epub 2018 Dec 8.

PMID:
30536422
11.

The association of hepatitis C infection with the onset of CKD and progression into ESRD.

Henson JB, Sise ME.

Semin Dial. 2018 Nov 29. doi: 10.1111/sdi.12759. [Epub ahead of print]

PMID:
30496620
12.

ESRD patients coinfected with human immunodeficiency virus and Hepatitis C: Outcomes and management challenges.

Sawinski D.

Semin Dial. 2018 Nov 26. doi: 10.1111/sdi.12765. [Epub ahead of print]

PMID:
30475425
13.

Therapy and Management of Pneumocystis jirovecii Infection.

White PL, Price JS, Backx M.

J Fungi (Basel). 2018 Nov 22;4(4). pii: E127. doi: 10.3390/jof4040127. Review.

14.

Darunavir-cobicistat-emtricitabine-tenofovir alafenamide: safety and efficacy of a protease inhibitor in the modern era.

Squillace N, Bozzi G, Colella E, Gori A, Bandera A.

Drug Des Devel Ther. 2018 Oct 29;12:3635-3643. doi: 10.2147/DDDT.S147493. eCollection 2018. Review.

15.

Minimal change nephrotic syndrome in patients infected with human immunodeficiency virus: a retrospective study of 8 cases.

Arrestier R, Satie AP, Zhang SY, Plaisier E, Isnard-Bagnis C, Gatault P, Raimbourg Q, Buob D, Vocila F, Heng AE, Francois H, Moktefi A, Canaud G, Matignon M, Dejucq-Rainsford N, Brocheriou I, Sahali D, Audard V.

BMC Nephrol. 2018 Nov 20;19(1):331. doi: 10.1186/s12882-018-1132-x.

16.

Epstein - Barr virus association with plasma cell neoplasms.

Nael A, Wu WW, Siddiqi I, Zhao X, Kahlon KS, Rezk SA.

Histol Histopathol. 2018 Nov 19:18066. doi: 10.14670/HH-18-066. [Epub ahead of print]

PMID:
30452079
17.

Acute kidney injury in HIV-infected patients: a critical review.

Gameiro J, Agapito Fonseca J, Jorge S, Lopes JA.

HIV Med. 2019 Feb;20(2):77-87. doi: 10.1111/hiv.12685. Epub 2018 Nov 8. Review.

PMID:
30411475
18.

Prevalence and genotyping of Pneumocystis jirovecii in renal transplant recipients-preliminary report.

Szydłowicz M, Jakuszko K, Szymczak A, Piesiak P, Kowal A, Kopacz Ż, Wesołowska M, Lobo ML, Matos O, Hendrich AB, Kicia M.

Parasitol Res. 2019 Jan;118(1):181-189. doi: 10.1007/s00436-018-6131-0. Epub 2018 Nov 3.

PMID:
30392033
19.

Pneumocystis jirovecii pneumonia (PCP) PCR-negative conversion predicts prognosis of HIV-negative patients with PCP and acute respiratory failure.

Choi JS, Lee SH, Leem AY, Song JH, Kim SY, Chung KS, Jung JY, Kang YA, Kim YS, Chang J, Park MS.

PLoS One. 2018 Oct 25;13(10):e0206231. doi: 10.1371/journal.pone.0206231. eCollection 2018.

20.

Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection.

Tio M, Rai R, Ezeoke OM, McQuade JL, Zimmer L, Khoo C, Park JJ, Spain L, Turajlic S, Ardolino L, Yip D, Goldinger SM, Cohen JV, Millward M, Atkinson V, Kane AY, Ascierto PA, Garbe C, Gutzmer R, Johnson DB, Rizvi HA, Joshua AM, Hellmann MD, Long GV, Menzies AM.

Eur J Cancer. 2018 Nov;104:137-144. doi: 10.1016/j.ejca.2018.09.017. Epub 2018 Oct 20.

PMID:
30347289

Supplemental Content

Loading ...
Support Center